Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04314284 · ClinicalTrials.gov registry record · NA
Patient-Centered Intervention to Reduce Cancer Patients' Financial Toxicity
A NA study of Lung Cancer and Colorectal Cancer, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT04314284: Completed NA study of Lung Cancer and Colorectal Cancer, sponsored by Washington University School of Medicine.
NCT04314284 is a NA study of Lung Cancer and Colorectal Cancer that has completed, run by Washington University School of Medicine. The registered enrollment target is 150 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04314284, a NA study of Lung Cancer and Colorectal Cancer, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to incorporate feedback from cancer patients and providers to adapt, implement, and test an intervention. The intervention aims to prompt screening for financial distress, facilitate discussions about care costs with cancer patients, support health insurance selection, and ultimately reduce cancer patients' financial toxicity associated with cancer care.
Primary Outcome
* Health insurance knowledge will be collected on the historical control survey and the I Can PIC post-intervention survey * Score from 0% (worst) to 100% (best). Higher scores indicate greater health insurance knowledge
Conditions Studied
Interventions
- BEHAVIORAL I Can PIC
- OTHER Historical control survey
- OTHER Post-intervention survey (I Can PIC participants)
- OTHER Follow-Up survey (I Can PIC participants)
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2020-05-26 |
| Est. Completion | 2021-11-04 |
| Phase | NA |
What the finished NCT04314284 record still lists
NCT04314284 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (84% lower).
The record links to 3 conditions, with Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which I Can PIC is the first listed.
NCT04314284 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04314284 about?
NCT04314284 is a clinical study titled "Patient-Centered Intervention to Reduce Cancer Patients' Financial Toxicity". The purpose of this study is to incorporate feedback from cancer patients and providers to adapt, implement, and test an intervention. The intervention aims to prompt screening for financial distress, facilitate discussions about care costs with cancer patients, support health insurance selection, a...
What is the current status of trial NCT04314284?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2020-05-26. Estimated completion is 2021-11-04.
What conditions does trial NCT04314284 study?
This clinical trial studies the following conditions: Lung Cancer, Colorectal Cancer, Gynecologic Cancer.
What interventions are being tested in trial NCT04314284?
The interventions under investigation include: I Can PIC (BEHAVIORAL), Historical control survey (OTHER), Post-intervention survey (I Can PIC participants) (OTHER), Follow-Up survey (I Can PIC participants) (OTHER).
Who is sponsoring clinical trial NCT04314284?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04314284 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04314284's enrollment target sits among peer trials
150 148th of 409 higher than 260 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI